Once a Notorious Short Seller, Martin Shkreli Now Sees A Future In Biotech
4/17/2014 8:14:23 AM
Martin Shkreli doesn’t sit still. Slouching in a modern black chair at the Manhattan offices of Retrophin (RTRX), the biotechnology company he started three years ago, he fiddles with a keyboard connected to a wall-mounted monitor, multitasking even as he gives an interview. As he talks, he flips through a copy of the Journal of the American Medical Association. He tugs at the blue hoodie he’s wearing over a crimson golf shirt and jeans. He’s 31 years old but could easily pass for an undergraduate.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by